Tamarly Intelligence

Every market, sourced and on one screen.

Tamarly Intelligence is Tamarly's research platform for subscribers, covering country risk, companies, funds, sectors, markets, life sciences and digital assets, with every figure sourced and dated. It updates through the day and publishes a morning edition at 6 AM New York time.

Stop-motion, 7 seconds
218countries scored every day
18,747companies with a page
15,356private fund managers
61,447clinical trials followed
21,549listings on 282 exchanges
22sectors, 8 cross-cutting views

Figures from the platform on 9 October 2026. Every figure on the platform shows its source, its date and a quality grade.

Inside the app

What does Tamarly Intelligence cover?

Twelve connected parts share one set of companies, funds, countries and sectors, so a fund links to the companies it holds, a company links to its countries and its trials, and every country page shows its market, its funds and its licensed crypto firms. Data comes from official registers and open sources, never from paid feeds.

Desk and the Wall

Your home screen. Every news item, filing, rule and risk event is a post you can save, share, hide, like or dislike, and the ranking learns from what you keep. A morning edition lands at 6 AM New York time with written briefs.

Risk Atlas

Political and country risk for 218 countries: a score from 0 to 100 updated daily, 19 themes, regional views, election calendars, a United States desk and a wall of risk events under the map.

Companies

One dashboard per company: 5 years of financials, filings read with a quote for every event, ownership and insider trades, news, sentiment and its drivers, country exposure and, for drug makers, the full pipeline.

Funds

2,687 funds with holdings and fees, and 15,356 private fund managers from the SEC and EU registers, with their private funds, markets and the companies they back.

Markets

282 stock exchanges from the ISO register, 21,549 listings, indices and the funds that give access to each market, country by country.

Sectors

The 22 official ISIC sections with employment, value added, emissions, rules and news, plus views investors use: energy, mining, semiconductors, defence, shipping, pharma and finance.

Life Sciences

61,447 industry trials, every FDA drug, biologic and device decision, patents and exclusivity dates, adverse event counts, therapeutic areas and a Pipeline tab on every drug maker.

Digital Assets

Coins and stablecoins, the 562 firms licensed or flagged under the EU's MiCA rules, and the trusts and ETFs that hold each coin, linked to every country page.

Reports

The Tamarly Research catalogue of 106 reports, read in the app, with company and country deep dives, case studies and sector reports.

Productivity Hub

Write memos and market reviews with live platform data, charts and citations. Templates include a 6-section investment memo; co-edit, comment, then export to PDF, Word or PowerPoint.

Portfolio and My Funds

Your holdings, encrypted before they are stored, with country and sector exposure, stress tests and alerts. Fund managers run their own funds, ledgers and KPI reports.

Search and export

One search across every country, company, fund, report and video, in English or French. Any page exports to PDF, Word, PowerPoint, Excel, CSV or Markdown with its sources.

Sample screens

What does a day on the platform look like?

At 6 AM New York time the morning edition refreshes the carousels and writes the day's briefs. Through the day the Wall adds filings, rules, risk events, FDA decisions and news every 15 minutes, and each post can be saved, shared or hidden.

Tamarly Intelligence

The Wall

Posts from filings, rules, risk events and news, ranked for you.

For youSavedArchived
06:00FDA approval of a new obesity medicineNovel approval, priority review. Opens the sponsor's Pipeline tab.
07:128-K filed: chief financial officer appointedEvent read from the filing, with the quote it rests on.
08:30Country risk up 6 points after a contested electionPolitics and security themes moved; brief updated.
09:05Private fund raise filed, $1.2BSEC Form D, linked to the manager's page.

Sample screens. Headlines on this page are illustrative.

Plans

How much does Tamarly Intelligence cost?

There are 4 plans, billed monthly and cancellable at any time. Level 2 opens the full platform for $35 a month and can be tried free for 7 days; Level 3 adds every catalogue report, Digital Assets and the investment memo builder.

Free

$0

The Tamarly Newsletter and public pages.

Level 1

$15 a month

Monthly reports and the research pages, including Life Sciences.

Level 2

$35 a month

Level 1 plus the Desk, the Wall, the Risk Atlas, companies, funds, markets, portfolio and alerts. A 7-day trial is available.

Level 3

$399 a month

Everything: every catalogue report, Digital Assets, the investment memo builder and the Productivity Hub without limits.

Where does the data come from?

From official registers and open sources: SEC EDGAR, ESMA and FCA registers, ClinicalTrials.gov and the FDA, the World Bank, the ISO exchange register, GDELT news, Wikidata and ChEMBL, plus Tamarly Research. Every value carries its source, its date and a grade from A to D, and nothing comes from paid market data feeds.

How often does it change?

The Wall and news refresh every 15 minutes, filings are read through the day, country scores and trials update daily, and the morning edition rewrites the carousels and briefs at 6 AM New York time. Registers of funds and licensed firms refresh weekly or monthly.

Is Tamarly Intelligence investment advice?

No. Tamarly Intelligence is research and information. Its AI writes summaries, briefs and memo sections from cited sources and never gives a buy or sell view; the reader decides. Life Sciences pages are market research, not clinical guidance.

How do I access Tamarly Intelligence?

Tamarly Intelligence runs at app.tamarly.ai. Sign in with Google, Microsoft or email, choose a plan, and you land on the Desk.

Tamarly Newsletter

One email a week on AI, capital markets and institutional power.

Read by more than 6,000 professionals. Free to subscribe.

Ask for a demo

Tell us who you are and what you follow; we show the platform to teams on a short call.